Epizyme, Inc. (EPZM): Price and Financial Metrics
Epizyme, Inc. (EPZM)
Today's Latest Price: $15.28 USD
1.38 (9.93%)
Updated Apr 6 4:00pm
Add EPZM to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
EPZM Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for EPZM is 0.07 -- better than only 10.71% of US stocks.
- With a price/sales ratio of 68.34, Epizyme Inc has a higher such ratio than 98.04% of stocks in our set.
- With a year-over-year growth in debt of 65,795.65%, Epizyme Inc's debt growth rate surpasses 99.84% of about US stocks.
- If you're looking for stocks that are quantitatively similar to Epizyme Inc, a group of peers worth examining would be MOR, SYRS, CDXS, AGYS, and ETON.
- Visit EPZM's SEC page to see the company's official filings. To visit the company's web site, go to www.epizyme.com.
EPZM Daily Price Range
EPZM 52-Week Price Range
EPZM Stock Price Chart More Charts
EPZM Price/Volume Stats
| Current price | $15.28 | 52-week high | $27.82 |
| Prev. close | $13.90 | 52-week low | $9.73 |
| Day low | $14.26 | Volume | 1,069,060 |
| Day high | $15.60 | Avg. volume | 1,135,089 |
| 50-day MA | $19.80 | Dividend yield | N/A |
| 200-day MA | $16.13 | Market Cap | 1.54B |
Epizyme, Inc. (EPZM) Company Bio
Epizyme, Inc. discovers and develops epigenetic therapies for cancer patients. The company was founded in 2007 and is based in Cambridge, Massachusetts.
Top Stories View All
Best & Worst Performing Stock Industries for April 6, 2020
Best & Worst Performing Small Cap Stocks for April 6, 2020
Best & Worst Performing Mid Cap Stocks for April 6, 2020
Best & Worst Performing Large Cap Stocks for April 6, 2020
Best & Worst Performing Mega Cap Stocks for April 6, 2020
View All Top Stories
Loading social stream, please wait...